BRPI1007917A2 - método para avaliar a situação renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal - Google Patents

método para avaliar a situação renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal

Info

Publication number
BRPI1007917A2
BRPI1007917A2 BRPI1007917A BRPI1007917A BRPI1007917A2 BR PI1007917 A2 BRPI1007917 A2 BR PI1007917A2 BR PI1007917 A BRPI1007917 A BR PI1007917A BR PI1007917 A BRPI1007917 A BR PI1007917A BR PI1007917 A2 BRPI1007917 A2 BR PI1007917A2
Authority
BR
Brazil
Prior art keywords
renal
markers
individual
assessing
status
Prior art date
Application number
BRPI1007917A
Other languages
English (en)
Inventor
Gray Jeff
Anderberg Joseph
Nakamura Kevin
Mcpherson Paul
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of BRPI1007917A2 publication Critical patent/BRPI1007917A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1007917A 2009-02-06 2010-02-05 método para avaliar a situação renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal BRPI1007917A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US15037409P 2009-02-06 2009-02-06
US15037209P 2009-02-06 2009-02-06
US15039309P 2009-02-06 2009-02-06
US16240209P 2009-03-23 2009-03-23
US16239609P 2009-03-23 2009-03-23
US16633309P 2009-04-03 2009-04-03
PCT/US2010/023292 WO2010091231A1 (en) 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
BRPI1007917A2 true BRPI1007917A2 (pt) 2019-09-24

Family

ID=42542388

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007917A BRPI1007917A2 (pt) 2009-02-06 2010-02-05 método para avaliar a situação renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal

Country Status (11)

Country Link
US (1) US20160123996A1 (pt)
EP (1) EP2393937A4 (pt)
JP (3) JP2012517592A (pt)
CN (3) CN102369293B (pt)
AU (1) AU2010210535B2 (pt)
BR (1) BRPI1007917A2 (pt)
CA (1) CA2751424A1 (pt)
HK (1) HK1200218A1 (pt)
MX (1) MX2011008323A (pt)
NZ (1) NZ630621A (pt)
WO (1) WO2010091231A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735590A1 (en) 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2766228A1 (en) * 2009-07-02 2011-01-06 Mosaiques Diagnostics And Therapeutics Ag Process and markers for the diagnosis of acute renal failure
EA201390294A1 (ru) * 2010-09-24 2013-09-30 Астьют Медикал, Инк. Способы и композиции для оценки повреждения почек с применением гиалуроновой кислоты
WO2014028339A1 (en) * 2012-08-11 2014-02-20 Astute Medical, Inc. Evaluating renal injury using hyaluronic acid
WO2014120677A1 (en) * 2013-01-29 2014-08-07 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US10300108B2 (en) * 2013-12-03 2019-05-28 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CL2015003047A1 (es) * 2015-10-15 2016-06-17 Univ Chile Método ex vivo para detectar precozmente injuria renal aguda en pacientes críticos, que comprende la mediciom en una muestra de tres proteinas como biomarcadores, factor de crecimiento fibroblástico 23, klotho y eritropoyetina
CN105466984B (zh) * 2016-01-14 2018-12-28 郑以山 用于肾脏非显性损伤的预警装置及其使用方法
EP3410119B1 (en) * 2016-01-29 2021-03-17 Karydo Therapeutix, Inc. Renal function evaluating device, device for predicting onset of kidney disease complications, and phosphorous ingestion amount estimating device
CN106845140A (zh) * 2017-03-01 2017-06-13 重庆工商大学 一种基于尿比重和尿量监测的肾衰竭预警方法及系统
EP3631459A1 (en) * 2017-05-30 2020-04-08 SphingoTec GmbH A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
CN109897108B (zh) * 2019-03-11 2021-04-02 上海恒赛生物科技有限公司 抗人内皮蛋白c受体的羊驼单域抗体及应用
EP3881862A1 (de) * 2020-03-18 2021-09-22 Pharis Biotec GmbH Polypeptid zur therapie von glomerulären nierenerkrankungen und analyse des verlaufes und prognose der abhängigen syndrome

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3569577B2 (ja) * 1995-09-04 2004-09-22 株式会社いかがく 腎・尿路系疾患の鑑別診断用キット
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
US6228360B1 (en) * 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
JP2003030100A (ja) * 2001-07-12 2003-01-31 Fuji Xerox Co Ltd インターネット情報提供システムおよびインターネット情報提供方法
ES2268961B1 (es) * 2005-03-17 2008-03-16 Proyecto De Biomedicina Cima, S.L. Nueva proteina epcr soluble de origen no proteolitico y su uso.
AU2006272913B2 (en) * 2005-07-21 2012-01-19 The Johns Hopkins University Methods of detecting and treating acute kidney injury
TW200726845A (en) * 2006-01-02 2007-07-16 Nat Defense Medical Ct Biomarker molecular of renal illness and detecting method for the same
US7662578B2 (en) * 2006-04-21 2010-02-16 Children's Hospital Medical Center Method and kit for the early detection of impaired renal status
US20080038269A1 (en) * 2006-05-25 2008-02-14 Mount Sinai Hospital Methods for detecting and treating kidney disease
GB0617429D0 (en) * 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
WO2008060607A2 (en) * 2006-11-14 2008-05-22 Biosite Incorporated Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
JP5661457B2 (ja) * 2007-06-06 2015-01-28 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． 腎疾患の予測診断

Also Published As

Publication number Publication date
US20160123996A1 (en) 2016-05-05
CN104111336A (zh) 2014-10-22
EP2393937A1 (en) 2011-12-14
WO2010091231A1 (en) 2010-08-12
JP2016194526A (ja) 2016-11-17
CA2751424A1 (en) 2010-08-12
MX2011008323A (es) 2011-09-21
HK1200218A1 (en) 2015-07-31
AU2010210535A1 (en) 2011-09-15
JP2015096870A (ja) 2015-05-21
HK1162617A1 (en) 2012-08-31
CN104111336B (zh) 2017-01-18
EP2393937A4 (en) 2012-08-08
AU2010210535B2 (en) 2015-12-10
CN106546752A (zh) 2017-03-29
CN102369293A (zh) 2012-03-07
NZ630621A (en) 2016-03-31
CN102369293B (zh) 2014-05-28
JP2012517592A (ja) 2012-08-02

Similar Documents

Publication Publication Date Title
BRPI0919640A2 (pt) método para avaliar a situação renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
BRPI0922021A2 (pt) método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
BRPI0917711A2 (pt) método para avaliar o estado renal em um paciente, e, uso de um ou mais marcadores de lesão renal
BRPI0921921A2 (pt) método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal.
BRPI1007917A2 (pt) método para avaliar a situação renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
BR112012016268A2 (pt) método para realizar relatórios de estado de memória temporária, sistema para realizar relatórios de estado de memória temporária e equipamento de usuário para realizar relatórios de estado de memória temporária
BRPI1015133A2 (pt) sistemas para o gerenciamento de diabetes e métodos
BRPI0816349A2 (pt) sistema, sistema para uso em um poço, e método
IL233095A0 (en) Ratio based biomarkers and methods of use thereof
BRPI1014229A2 (pt) método para prover desenvolvimento do gerenciamento de terapia, e, plataforma de desenvolvimento de gerenciamento de terapia
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
BRPI0910608A2 (pt) métodos e sistemas para avaliar resultados clínicos
PT2849381T (pt) Disposição e método para a identificação de recursos no formato 3 de pucch
BRPI0921579A2 (pt) método para ligar dinamicamente programa em plataforma embutida e plataforma embutida
BR112013000364A2 (pt) conjuntos, sistemas e métodos para a reparação do acetábulo
BR112013013888A2 (pt) sistemas e métodos para monitoramento de poço
BRPI0910408A2 (pt) equipamento e método para gerenciamento de memória relacionado a widget.
BRPI0818011A2 (pt) Método e dispositivo para associar objetos
BRPI1004574A2 (pt) pastilha de corte com fornecimento de refrigerante e método para a elaboração da pastilha de corte
BRPI0909002A2 (pt) aparelho para uso em um poço, sistema, e método para uso em um poço
BR112012032962A2 (pt) composição para utilização em um furo de poço, composição em gel para utilização em um furo de poço, e método.
BRPI0820148A2 (pt) Sistema de aberturas, sistema de computador e método para usinar aberturas
BRPI0919521A2 (pt) sistemas e métodos para a pré-diluição de edulcorantes
BR112013010272A2 (pt) métodos analíticos e arranjos para uso nos mesmos
BRPI0915492A2 (pt) sistemas e métodos para transferir valores

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.